UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total revenue	$ 721.7	$ 685.3
Total cost of revenue	368.9	325.6
Gross profit	352.8	359.7
Operating expenses:
Selling, general and administrative	195.3	162.7
Research and development	81.8	69.0
Other charges, net	10.9	5.3
Total operating expenses	288.0	237.0
Operating income	64.8	122.7
Interest and other income (expense), net	6.8	(16.1)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	71.6	106.6
Income tax provision	19.8	29.9
Equity in income of unconsolidated investees, net of tax	0.2	0.7
Net income	52.0	77.4
Net income attributable to noncontrolling interests in consolidated subsidiaries	1.1	0.9
Net income attributable to Bruker Corporation	$ 50.9	$ 76.5
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.35	$ 0.52
Diluted	$ 0.35	$ 0.52
Weighted average common shares outstanding:
Basic	145.2	146.8
Diluted	145.9	147.6
Product
Total revenue	$ 586.9	$ 567.1
Total cost of revenue	291.7	257.2
Other
Total revenue	134.8	118.2
Total cost of revenue	$ 77.2	$ 68.4